Updated Feb 13, 2018

PremieBreathe

The innovation has no owner

CLAIM IT

Snapshot

Focus Areas:

Maternal Newborn and Child Health

Maternal Newborn and Child HealthSEE LESS

Implemented In:

Ethiopia

EthiopiaSEE LESS

1
Country Implemented In
Verified Funding

Innovation Description

PremieBreathe has built a functional infant breathing aid for $450, one tenth the price of commercial models. The device, a humidified high flow nasal cannula (HHFNC), is the gold standard of non-invasive neonatal respiratory care in high-income countries. With the support of Saving Lives at Birth, PremieBreathe will conduct initial trials at Ayder Referral Hospital in the Tigray region of Ethiopia, and identify design, manufacturing, and distribution partners to prepare for scaled production and dissemination.

Milestones

Nov 2016
Date Unknown
New Country
Ethiopia